M25.539 Medicare coverage policies

24 active Medicare policies list M25.539. See each policy's status for the code and its official source. Listing a code is not a coverage decision: read each policy’s source for the requirements that apply.

Get free alerts for M25.539

Free account. Policy pages stay open to everyone.

Medicare policies listing M25.539

LCD · NORIDIAN-JE-L39116

Amniotic and Placental-Derived Product Injections and/or Applications for Musculoskeletal Indications, Non-Wound

JE · Effective Nov 12, 2023

LCD · NORIDIAN-JF-L39116

Amniotic and Placental-Derived Product Injections and/or Applications for Musculoskeletal Indications, Non-Wound

JF · Effective Nov 12, 2023

LCD · PALMETTO-JJ-L39128

Amniotic and Placental-Derived Product Injections and/or Applications for Musculoskeletal Indications, Non-Wound

JJ · Effective Apr 30, 2023

LCD · PALMETTO-JM-L39128

Amniotic and Placental-Derived Product Injections and/or Applications for Musculoskeletal Indications, Non-Wound

JM · Effective Apr 30, 2023

LCD · FIRST_COAST-L33933

Peripheral Nerve Blocks

J9 · Effective Oct 1, 2015

LCD · NORIDIAN-JE-L34211

Trigger Point Injections (TPI)

JE · Effective Oct 1, 2015

LCD · NORIDIAN-JF-L34211

Trigger Point Injections (TPI)

JF · Effective Oct 1, 2015

LCD · PALMETTO-JJ-L39671

Trigger Point Injections (TPI)

JJ · Effective Mar 31, 2024

LCD · PALMETTO-JM-L39671

M25.539 Medicare coverage policies

Medicare policies listing M25.539

Amniotic and Placental-Derived Product Injections and/or Applications for Musculoskeletal Indications, Non-Wound

Amniotic and Placental-Derived Product Injections and/or Applications for Musculoskeletal Indications, Non-Wound

Amniotic and Placental-Derived Product Injections and/or Applications for Musculoskeletal Indications, Non-Wound

Amniotic and Placental-Derived Product Injections and/or Applications for Musculoskeletal Indications, Non-Wound

Peripheral Nerve Blocks

Trigger Point Injections (TPI)

Trigger Point Injections (TPI)

Trigger Point Injections (TPI)

Trigger Point Injections (TPI)

M25.539 Medicare coverage policies

Medicare policies listing M25.539

Amniotic and Placental-Derived Product Injections and/or Applications for Musculoskeletal Indications, Non-Wound

Amniotic and Placental-Derived Product Injections and/or Applications for Musculoskeletal Indications, Non-Wound

Amniotic and Placental-Derived Product Injections and/or Applications for Musculoskeletal Indications, Non-Wound

Amniotic and Placental-Derived Product Injections and/or Applications for Musculoskeletal Indications, Non-Wound

Peripheral Nerve Blocks

Trigger Point Injections (TPI)

Trigger Point Injections (TPI)

Trigger Point Injections (TPI)

Trigger Point Injections (TPI)

Urine Drug Testing

Billing and Coding: Amniotic and Placental-Derived Product Injections and/or Applications for Musculoskeletal Indications, Non-Wound

Billing and Coding: Amniotic and Placental-Derived Product Injections and/or Applications for Musculoskeletal Indications, Non-Wound

Billing and Coding: Amniotic and Placental-Derived Product Injections and/or Applications for Musculoskeletal Indications, Non-Wound

Billing and Coding: Amniotic and Placental-Derived Product Injections and/or Applications for Musculoskeletal Indications, Non-Wound

Billing and Coding: Amniotic and Placental-Derived Product Injections and/or Applications for Musculoskeletal Indications, Non-Wound

Billing and Coding: Amniotic and Placental-Derived Product Injections and/or Applications for Musculoskeletal Indications, Non-Wound

Billing and Coding: Peripheral Nerve Blocks

Billing and Coding: Trigger Point Injections

Billing and Coding: Trigger Point Injections (TPI)

Billing and Coding: Trigger Point Injections (TPI)

Billing and Coding: Trigger Point Injections (TPI)

Billing and Coding: Trigger Point Injections (TPI)

Billing and Coding: Urine Drug Testing

Billing and Coding: Zika Virus Testing by PCR and ELISA Methods